Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels

Waldencast plc (NASDAQ:WALD) is one of the Best 52-Week Low Penny Stocks to Buy Now. On July 23, Waldencast plc (NASDAQ:WALD) announced the acquisition of Novaestiq Corp. and the US rights to the Saypha line of hyaluronic acid injectable gels.

This strategic acquisition expands Obagi Medical’s offerings beyond skincare into the dermal filler market in the US. Management noted that the skincare market is expected to reach $2.2 billion by 2029, while the dermal filler market is projected at $2 billion. The acquisition doubles the company’s addressable market.

Waldencast plc (NASDAQ:WALD) will now offer injectable HA gels named Saypha to integrate medical-grade skincare with aesthetic treatments for better, longer-lasting results and higher patient satisfaction.

Waldencast plc (NASDAQ:WALD) is an international beauty and wellness company that develops purpose-driven brands.

While we acknowledge the potential of WALD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.